. Author manuscript; available in PMC: 2013 Jul 1.

Published in final edited form as: Neurobiol Learn Mem. 2012 Apr 26;98(1):41–46. doi: 10.1016/j.nlm.2012.04.007

Table 2.

Increase in errors above baseline following local intraperirhinal microinfusions

Infusion material in mM	Percent errors above baseline	Response latency in seconds
Infusion material in mM	Percent errors above baseline	sample phase	test phase
Saline	2.0 (2.3)	1.2 (0.1)	2.1 (0.2)
1.0 PIR	1.3 (2.3)	1.3 (0.3)	2.0 (0.3)
10.0 PIR	13.2 (1.6)^*	1.3 (0.2)	2.2 (0.2)
30.0 PIR	23.2 (3.5)^*	1.3 (0.2)	2.2 (0.3)
0.5 MET	2.6 (1.4)	1.2 (0.3)	2.0 (0.3)
1.0 MET	0.7 (1.1)	1.4 (0.3)	2.2 (0.4)
10.0 SCOP	17.1 (3.2)^*	1.4 (0.3)	2.5 (0.6)

Means (and SEMs) for each dose tested.

significant deficit (see Table 1 for p-values).